• METTL16–SENP3–LTF Axis in HCC Ferroptosis

  2026-08-27

  Wang et al. identify a METTL16–SENP3–LTF regulatory axis that links m6A RNA modification, SUMO-dependent protein stability, and iron handling to ferroptosis resistance in hepatocellular carcinoma. The study integrates cellular, organoid, mouse-model, biochemical, and human-sample evidence, providing a mechanistic framework for sensitizing HCC to ferroptosis-based interventions.

• Letrozole in Reliable Cell Assays

  2026-08-27

  This scenario-based guide shows how Letrozole, SKU A1307, can improve experimental consistency in cell viability, proliferation, and cytotoxicity workflows. It covers mechanism, DMSO compatibility, dose-response design, data interpretation, and practical criteria for selecting a reliable research reagent.

• Catalpol Activates Sirt6–ERα–FasL in Osteoporosis

  2026-08-26

  The reference study identifies a mechanistic link between Catalpol and osteoclast apoptosis in estrogen-deficiency osteoporosis. Using ovariectomized rats and RANKL-induced RAW 264.7 osteoclasts, the authors show that Catalpol promotes Sirt6-dependent ERα deacetylation, stabilizes ERα, and increases FasL-mediated apoptotic signaling.

• Epalrestat: From Polyol Flux to Nrf2 Assays

  2026-08-26

  Epalrestat is an aldose reductase inhibitor that connects polyol pathway inhibition with oxidative stress research. This article presents a mechanism-focused framework for selecting assays, interpreting KEAP1/Nrf2 findings, and translating evidence from diabetic neuropathy research into Parkinson’s disease models.

• α7nAChR Pyroptosis in HIV-1 BBB Breakdown

  2026-08-25

  The reference study identifies brain endothelial pyroptosis as a direct mechanism by which HIV-1 gp120 compromises blood–brain barrier integrity. It positions the α7nAChR/ROS/NF-κB/NLRP3 pathway as a targetable axis and reports that memantine and metformin can suppress this injury in experimental models.

• Sulfaphenazole Restores Vasodilation in Diabetic Mice

  2026-08-25

  The reference study identified CYP 2C-derived reactive oxygen species as a reversible contributor to endothelial dysfunction in db/db mice. Sulfaphenazole restored acetylcholine-mediated vasodilation while lowering oxidative stress and increasing nitric oxide bioavailability without changing plasma glucose, supporting a mechanistic link between cytochrome P450 activity and diabetic vascular injury.

• Abiraterone acetate in 3D Prostate Cancer Research

  2026-08-24

  Build a translational workflow that combines Abiraterone acetate with patient-derived prostate cancer spheroids, controlled exposure chemistry, and orthogonal androgen-response readouts. The approach helps distinguish CYP17 pathway effects from model-specific resistance, compound-access limitations, and direct androgen receptor activity inhibition.

• BKT140 (BL-8040) CXCR4 Research Workflows

  2026-08-24

  BKT140, also known as BL-8040, turns CXCR4 biology into measurable assays for chemotaxis, apoptosis, tumor microenvironment signaling, and stem cell mobilization. This workflow-led guide shows how to formulate the compound, select orthogonal readouts, and troubleshoot results across cancer and hematopoietic models.

• Protease Inhibitor Cocktail for OXPHOS Assays

  2026-08-23

  Protect intact signaling and mitochondrial proteins during cell and tissue extraction with an EDTA-free, broad-spectrum inhibitor format. This workflow shows how to use the cocktail in Western blotting, co-immunoprecipitation, kinase assays, and mechanistic OXPHOS studies without introducing chelation-related interference.

• Bone Transport, TGF-β1, and Diabetic Ulcer Healing

  2026-08-22

  A 2026 rat study shows that bone transport accelerates ischemic diabetic foot ulcer repair while activating TGF-β1/TGFBR1 signaling, angiogenesis, and osteo-immune responses. Its three-arm design and multi-omics validation provide a useful framework for testing pathway dependence, although the findings remain preclinical and should not be directly generalized to other TGF-β-driven diseases.

• A 83-01 and the Translational TGF-β–YAP1 Question

  2026-08-21

  The LPS/TLR4/YAP1 study in hepatocytes creates a compelling translational question: where does TGF-β signaling fit within niche-driven stemness? This article explains how A 83-01 can serve as a selective ALK-5 inhibitor for dissecting Smad-dependent transcription, EMT, organoid behavior, and liver repair hypotheses without overstating what current evidence proves.

• CA800-PR Targets PR and Golgi Stress in Breast Cancer

  2026-08-20

  The reference study introduces CA800-PR, a water-soluble heptamethine cyanine dye that combines tumor-associated uptake, near-infrared imaging, and antitumor activity in hormone receptor-positive breast cancer models. Its reported mechanism links Golgi fragmentation with selective progesterone receptor suppression, apoptosis, inflammatory signaling, and recruitment of MHC class II-positive, CD80-positive macrophages.

• Endothelial STING Signaling in Doxorubicin Cardiotoxicity

  2026-08-20

  The reference study proposes that cardiac vascular endothelial cells, rather than cardiomyocytes alone, initiate and amplify doxorubicin-induced cardiotoxicity through cGAS–STING activation, NLRP3 inflammasome-mediated pyroptosis, and pathogenic extracellular vesicles. It also identifies leonurine as a direct STING inhibitor that binds Tyr261, offering a mechanistically distinct strategy for interrupting endothelial-to-cardiomyocyte injury signaling.

• Epalrestat: From Polyol Flux to Nrf2 Assays

  2026-08-19

  Epalrestat is an aldose reductase inhibitor that connects polyol pathway inhibition with redox and KEAP1/Nrf2 biology. This article presents an evidence-based framework for selecting assays, controls, and handling conditions across diabetic neuropathy research and Parkinson’s disease models.

• Secreted METTL9 Defends the Gut Against Candida

  2026-08-19

  Bao and colleagues identify intestinal epithelial METTL9 as a secreted, catalytic antifungal effector that methylates the Candida albicans zincophore PRA1 and restricts fungal zinc acquisition. The study connects this cross-kingdom mechanism with reduced intestinal colonization and dissemination, activity against Candida auris, and lower METTL9 abundance in inflammatory bowel disease mucosa.

8399 records 1/560 page Next 12345 下5页 Last page